Real-time polymerase chain reaction in multiple myeloma-Reference-Cited by-同舟云学术

Real-time polymerase chain reaction in multiple myeloma

Published:2002-06 Issue:6 Volume:30 Page:529-536
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Ladetto Marco,Omedè Paola,Sametti Selina,Donovan John W.,Astolfi Monica,Drandi Daniela,Volpato Federica,Giaccone Luisa,Giaretta Fulvia,Palumbo Antonio,Bruno Benedetto,Pileri Alessandro,Gribben John G.,Boccadoro Mario

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference50 articles.

1. High-dose therapy and innovative approaches to treatment of multiple myeloma;Barlogie;Semin Hematol,2001

2. Recent advances in multiple myeloma;Sjak-Shie;Curr Opin Hematol,2000

3. Bone marrow transplantation in multiple myeloma;Schlossman;Curr Opin Oncol,1999

4. The role of high-dose chemotherapy in the treatment of multiple myeloma;Kyle;Ann Oncol,2000

5. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. The Intergroupe Français du Myélome;Attal;N Engl J Med,1996

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advances in estimating plasma cells in bone marrow: A comprehensive method review;African Journal of Laboratory Medicine;2024-07-11

2. Dynamics of tumor‐specific cfDNA in response to therapy in multiple myeloma patients;European Journal of Haematology;2019-12-20

3. A case control study of syngeneic transplantation versus autologous transplantation for multiple myeloma: two decades of experiences from a single center;Leukemia & Lymphoma;2017-07-03

4. Should minimal residual disease negativity not be the end point of myeloma therapy?;Blood Advances;2017-03-14

5. Detection of tumor-specific marker for minimal residual disease in multiple myeloma patients;Biomedical Papers;2015-12-03